Mortality in Patients with AIDS Treated with Either Foscarnet or Ganciclovir for CMV Retinitis
AIDS Res Group & AIDS Clin Trials Group, NEJM 326:213-220, 2642., , 1992
Treatment of Aggressive CMV Retinitis with Ganciclovir in Combination with Foscarnet in a Child Infected with HIV
J Pediatr 120:483-486, Butler,K.M.,et al, 1992
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Acute and Persistent Parkinsonism after Use of Diquat
Neurol 42:261-263, Sechi,G.P.,et al, 1992
Cerebromeningeal Haemophagocytic Lymphohistiocytosis
Lancet 239:104-107, Henter,J.&Elinder,G., 1992
Risk Factors for Delirium in Hospitalized Elderly
JAMA 267:827-831, Schor,J.D.,et al, 1992
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Neurocysticercosis and Human Immunodeficiency Virus Infection:A Possible Association
Arch Neurol 49:963-965, Thornton,C.A.,et al, 1992
Thromboendartectomy of the Symptomatic Occluded Internal Carotid Artery
J Neurosurg 76:752-758, McCormick,P.W.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Intravenous Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke
Neurol 42:976-982, Mori,E.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Serum Concentrations of Vitamins A and E and Early Outcome after Ischaemic Stroke
Lancet 339:1562-1565, DeKeyser,J.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Hyponatraemia and Death or Permanent Brain Damage in Healthy Children
BMJ 304:1218-1222, Arieff,A.I.,et al, 1992
Persistent Paralysis in Critically Ill Patients after Long-Term Administration of Vecuronium
NEJM 327:524-528, Segredo,V.,et al, 1992
Cancer Pain:Management
Lancet 339:1031-1036, Hanks,G.W.&Justins,D.M., 1992
Hypertensive Encephalopathy:Findings on CT, MR Imaging, and SPECT Imaging in 14 Cases
AJR 159:379-383, Schwartz,R.B.,et al, 1992
Improvement of Motor Performance of HIV-Positive Patients Under AZT Therapy
Neurol 42:891-896, Arendt,G.,et al, 1992
Altitude Induced Illness
BMJ 304:1324-1325, Pollard,A.J., 1992
Pathophysiology of Acute Ischaemic Stroke
Lancet 339:533-536, Pulsinelli,W., 1992
Excess Water Administration and Hyponatraemic Convulsions in Infancy
Editorial, Lancet, 339:153-155992., , 1992
Clinical Outcome in Aggressively Treated Meningeal Gliomatosis
Neurol 42:252-254, Grant,R.,et al, 1992
Clinical Trial of Nimodipine in Acute Ischemic Stroke
The American Nimodipine Study Group, Stroke 23:3-81992., , 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Radiation Necrosis vs High-Grade Recurrent Glioma:Differentiation by Using Dual-Isotope SPECT with 201TI and 99mTc-HMPAO
AJR 158:399-404, Schwartz,R.B.,et al, 1992
Fatal Meningoencephalitis Caused by Reactivation of Trypanosoma Cruzi Infection in a Patient with AIDS
Neurol 42:640-642, Rosemberg,S.,et al, 1992
Cerebral Infarction Complicating Intravenous Immunoglobulin Therapy for Polyneuritis Cranialis
Neurol 42:257-258, Silbert,P.L.,et al, 1992
Intraventricular Interferon and Oral Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis
Neurol 42:488-491, Yalaz,K.,et al, 1992
Multifocal Inflammatory Leukoencephalopathy with 5-Fluorouracil and Levamisole
Ann Neurol 31:262-267, Hook,C.C.,et al, 1992
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Non-Hodgkin's Lymphoma Secondary to Hodgkin's Disease Treated with Chemo-and Radiotherapy
Revista de Investigacion Clinica 44:393-398, Dominquez,G.A.,et al, 1992
Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Treatment of Ocular Herpes Zoster
Lancet 338:1244-1245, , 1991
Granulomatous Amebic Encephalitis in an AIDS Patient
Neurol 41:1993-1995, Gardner,H.A.R.,et al, 1991
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Cyclosporin in the Management of Polymyositis and Dermatomyositis
JNNP 54:1007-1008, Lueck,C.J.,et al, 1991
Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991
Magnetic REsonance Imaging of AIDS-Related Polyradiculopathy
Neurol 41:1996-1997, Talpos,D.,et al, 1991
Fatigue and Myalgia in AIDS Patients
Neurol 41:1603-1607, Miller,R.G.,et al, 1991
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991